| Insider-Aktien | 14.972.175 shares |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Dicerna Pharmaceuticals Inc Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in DRNA / Dicerna Pharmaceuticals Inc getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in DRNA / Dicerna Pharmaceuticals Inc. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 3,47 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam See footnotes | DRNA | Common Stock | I | 38,2500 | -3.080.237 | -117.819 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Koppel Adam | DRNA | Common Stock | D | 38,2500 | -3.333 | -127 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -68.100 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -121.300 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | -75.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 16,30 | -111.800 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | -180.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | -105.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -33.999 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -11.879 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | -11.325 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | -25.950 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Weissman James B | DRNA | Common Stock | D | 38,2500 | -18.100 | -692 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -46.120 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | -81.825 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | -13.669 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | -7.688 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Zeng Ling | DRNA | Common Stock | D | 38,2500 | -5.032 | -192 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 3,26 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 18,73 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 16,30 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 13,87 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | D | 38,2500 | -16.157 | -618 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 10,31 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 38,2500 | -5.000 | -191 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | KOZIN MARC D | DRNA | Common Stock | D | 38,2500 | -6.333 | -242 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -36.900 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 20,79 | -95.650 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | -6.150 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | -20.475 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 38,2500 | -7.775 | -297 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 14,32 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | GRAY PATRICK M. | DRNA | Common Stock | D | 38,2500 | -3.333 | -127 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Smith Cynthia | DRNA | Common Stock | D | 38,2500 | -3.333 | -127 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 3,26 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Freed Martin I | DRNA | Common Stock | D | 38,2500 | -3.333 | -127 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 15,61 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Doberstein Stephen K | DRNA | Common Stock | D | 38,2500 | -3.333 | -127 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -247.700 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -250.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | -225.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -225.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS By Trust | DRNA | Employee Stock Option (Right to Buy) | I | 16,30 | -200.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS By Trust | DRNA | Employee Stock Option (Right to Buy) | I | 16,30 | -200.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 16,30 | -71.900 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | -505.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | -255.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -55.055 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -281.250 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -191.330 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | -41.250 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | -59.850 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 38,2500 | -231.431 | -8.852 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -51.070 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | -124.700 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | -8.513 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | -21.075 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 38,2500 | -6.973 | -267 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -68.100 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -121.300 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | -75.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 16,30 | -165.050 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | -180.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | -105.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -85.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | -11.325 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | -25.950 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Brown Bob D | DRNA | Common Stock | D | 38,2500 | -2.367 | -91 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -61.500 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -76.144 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | -270.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | -17.325 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | -10.275 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 38,2500 | -14.813 | -567 | 0 | ||||
| 2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | -15.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | -21.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 15,44 | -33.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | -25.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,13 | -8.000 | 0 | |||||
| 2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-12-29 | 2021-12-28 | 4 | BUCHI J KEVIN | DRNA | Common Stock | D | 38,2500 | -4.666 | -178 | 0 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | -2.837 | 8.513 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 38,0500 | -833 | -32 | 6.973 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 2.837 | 7.806 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | -3.425 | 10.275 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 38,0500 | -1.241 | -47 | 14.813 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 3.425 | 16.054 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | -2.050 | 6.150 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 38,0500 | -602 | -23 | 7.775 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 2.050 | 8.377 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | -2.562 | 7.688 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Zeng Ling | DRNA | Common Stock | D | 38,0500 | -752 | -29 | 5.032 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Zeng Ling | DRNA | Common Stock | D | 2.562 | 5.784 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | -3.775 | 11.325 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Brown Bob D | DRNA | Common Stock | D | 38,0500 | -1.675 | -64 | 2.367 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Brown Bob D | DRNA | Common Stock | D | 3.775 | 4.042 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | -13.750 | 41.250 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 38,0500 | -5.348 | -203 | 231.431 | ||||
| 2021-12-17 | 2021-12-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 13.750 | 236.779 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | -3.775 | 11.325 | ||||||
| 2021-12-17 | 2021-12-15 | 4 | Weissman James B | DRNA | Common Stock | D | 38,0500 | -1.675 | -64 | 18.100 | ||||
| 2021-12-17 | 2021-12-15 | 4 | Weissman James B | DRNA | Common Stock | D | 3.775 | 19.775 | ||||||
| 2021-12-14 | 2021-12-13 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -8.856 | 76.144 | |||||
| 2021-12-14 | 2021-12-13 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 22,5800 | 8.856 | 200 | 12.629 | ||||
| 2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -146.195 | 55.055 | |||||
| 2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -33.670 | 191.330 | |||||
| 2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 146.195 | 500 | 223.029 | ||||
| 2021-12-13 | 2021-12-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 2,9700 | 33.670 | 100 | 76.834 | ||||
| 2021-11-22 | 2021-11-18 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -24.936 | 0 | |||||
| 2021-11-22 | 2021-11-18 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,9400 | -24.936 | -946 | 267 | ||||
| 2021-11-22 | 2021-11-18 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 24.936 | 85 | 25.203 | ||||
| 2021-09-21 | 2021-09-17 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0596 | -21.250 | -448 | 267 | ||||
| 2021-09-17 | 2021-09-17 | 4 | Zeng Ling | DRNA | Common Stock | D | 21,4700 | -1.334 | -29 | 3.222 | ||||
| 2021-09-17 | 2021-09-15 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | -4.556 | 13.669 | ||||||
| 2021-09-17 | 2021-09-15 | 4 | Zeng Ling | DRNA | Common Stock | D | 4.556 | 4.556 | ||||||
| 2021-09-17 | 2021-09-17 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 21,4700 | -2.056 | -44 | 4.969 | ||||
| 2021-09-17 | 2021-09-15 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | -7.025 | 21.075 | ||||||
| 2021-09-17 | 2021-09-15 | 4 | Aradhye Shreeram | DRNA | Common Stock | D | 7.025 | 7.025 | ||||||
| 2021-08-10 | 2021-08-10 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 22,0960 | 5.000 | 110 | 43.164 | ||||
| 2021-08-10 | 2021-08-10 | 4 | KOZIN MARC D | DRNA | Common Stock | D | 23,6620 | 3.000 | 71 | 6.333 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.312 | 24.936 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,3770 | -8.312 | -311 | 21.517 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.312 | 28 | 29.829 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | -1.712 | 11.988 | ||||||
| 2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | -1.450 | 7.250 | ||||||
| 2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 37,0500 | -1.404 | -52 | 2.027 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 1.712 | 3.431 | ||||||
| 2021-07-08 | 2021-07-06 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 1.450 | 1.719 | ||||||
| 2021-07-08 | 2021-07-06 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -30.000 | 33.999 | |||||
| 2021-07-08 | 2021-07-06 | 4 | Weissman James B | DRNA | Common Stock | D | 39,0900 | -30.000 | -1.173 | 16.000 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Weissman James B | DRNA | Common Stock | D | 9,0900 | 30.000 | 273 | 46.000 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.312 | 33.248 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,8466 | -1.066 | -40 | 21.517 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 37,3029 | -7.246 | -270 | 22.583 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.312 | 28 | 29.829 | ||||
| 2021-06-29 | 2021-06-25 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -1.000 | 49.221 | |||||
| 2021-06-29 | 2021-06-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 38,0037 | -1.000 | -38 | 269 | ||||
| 2021-06-29 | 2021-06-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,5800 | 1.000 | 23 | 1.269 | ||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -2.406 | 55.094 | |||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -2.279 | 50.221 | |||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -13.750 | 85.000 | |||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 36,7108 | -4.880 | -179 | 269 | ||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 37,0957 | -13.555 | -503 | 5.149 | ||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 24,0500 | 2.406 | 58 | 18.704 | ||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,5800 | 2.279 | 51 | 16.298 | ||||
| 2021-06-24 | 2021-06-22 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 13.750 | 178 | 14.019 | ||||
| 2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | -4.000 | 57.500 | |||||
| 2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -4.664 | 98.750 | |||||
| 2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 35,7881 | -8.664 | -310 | 269 | ||||
| 2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 24,0500 | 4.000 | 96 | 8.933 | ||||
| 2021-06-22 | 2021-06-17 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4.664 | 60 | 4.933 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | -6.825 | 20.475 | ||||||
| 2021-06-17 | 2021-06-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 35,7400 | -2.004 | -72 | 5.760 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Pagan Douglas W. | DRNA | Common Stock | D | 6.825 | 7.764 | ||||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 26,62 | -1.564 | 5.261 | |||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | -10.000 | 52.500 | |||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -20.000 | 103.414 | |||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 36,1500 | -100 | -4 | 269 | ||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 35,6284 | -31.464 | -1.121 | 369 | ||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 26,6200 | 1.564 | 42 | 31.833 | ||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,5800 | 10.000 | 226 | 30.269 | ||||
| 2021-06-17 | 2021-06-16 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 20.000 | 259 | 20.269 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | -381 | 1.144 | ||||||
| 2021-06-17 | 2021-06-15 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 35,7400 | -112 | -4 | 269 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 381 | 381 | ||||||
| 2021-06-15 | 2021-06-14 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | -20.000 | 270.000 | |||||
| 2021-06-15 | 2021-06-14 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 38,0000 | -20.000 | -760 | 3.773 | ||||
| 2021-06-15 | 2021-06-14 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 15,6100 | 20.000 | 312 | 23.773 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | -10.000 | 290.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 35,0000 | -10.000 | -350 | 3.773 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 15,6100 | 10.000 | 156 | 13.773 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -10.000 | 85.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 34,0000 | -10.000 | -340 | 21.517 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10.000 | 91 | 31.517 | ||||
| 2021-06-08 | 2021-06-07 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -10.000 | 95.000 | |||||
| 2021-06-08 | 2021-06-07 | 4 | Brown Bob D | DRNA | Common Stock | D | 33,0000 | -10.000 | -330 | 21.517 | ||||
| 2021-06-08 | 2021-06-07 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10.000 | 91 | 31.517 | ||||
| 2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | D | 3.333 | 29.071 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Freed Martin I | DRNA | Common Stock | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Smith Cynthia | DRNA | Common Stock | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | KOZIN MARC D | DRNA | Common Stock | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | GRAY PATRICK M. | DRNA | Common Stock | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Protopapas Anna | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Protopapas Anna | DRNA | Common Stock | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | -4.666 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | BUCHI J KEVIN | DRNA | Common Stock | D | 4.666 | 4.666 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Doberstein Stephen K | DRNA | Common Stock | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 30,47 | 15.000 | 15.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | -3.333 | 0 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | Koppel Adam | DRNA | Common Stock | D | 3.333 | 3.333 | ||||||
| 2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -4.431 | 123.414 | |||||
| 2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 31,9687 | -305 | -10 | 0 | ||||
| 2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 30,8599 | -4.126 | -127 | 305 | ||||
| 2021-06-03 | 2021-06-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4.431 | 57 | 4.431 | ||||
| 2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.312 | 41.560 | |||||
| 2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 32,0165 | -342 | -11 | 21.517 | ||||
| 2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 30,8818 | -7.970 | -246 | 21.859 | ||||
| 2021-06-03 | 2021-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.312 | 28 | 29.829 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -4.431 | 127.845 | |||||
| 2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 31,2485 | -475 | -15 | 0 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 30,1692 | -3.956 | -119 | 475 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4.431 | 57 | 4.431 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.312 | 49.872 | |||||
| 2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 31,6600 | -24 | -1 | 21.517 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 31,0103 | -1.135 | -35 | 21.541 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 30,1574 | -7.153 | -216 | 22.676 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.312 | 28 | 29.829 | ||||
| 2021-05-03 | 2021-04-30 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -10.000 | 105.000 | |||||
| 2021-05-03 | 2021-04-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 32,0000 | -10.000 | -320 | 21.517 | ||||
| 2021-05-03 | 2021-04-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10.000 | 91 | 31.517 | ||||
| 2021-05-03 | 2021-04-29 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -10.000 | 115.000 | |||||
| 2021-05-03 | 2021-04-29 | 4 | Brown Bob D | DRNA | Common Stock | D | 31,0000 | -10.000 | -310 | 21.517 | ||||
| 2021-05-03 | 2021-04-29 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 10.000 | 91 | 31.517 | ||||
| 2021-04-20 | 2021-04-16 | 4 | Weissman James B | DRNA | Common Stock | D | 29,9900 | -4.904 | -147 | 16.000 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.312 | 58.184 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 26,4950 | -188 | -5 | 21.517 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,8548 | -8.124 | -210 | 21.705 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.312 | 28 | 29.829 | ||||
| 2021-04-05 | 2021-03-01 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.312 | 66.496 | |||||
| 2021-04-05 | 2021-03-01 | 4/A | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.312 | 28 | 29.829 | ||||
| 2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -5.246 | 0 | |||||
| 2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -3.066 | 74.808 | |||||
| 2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 5.246 | 16 | 29.829 | ||||
| 2021-04-05 | 2021-02-03 | 4/A | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 3.066 | 10 | 24.583 | ||||
| 2021-04-05 | 2021-01-25 | 4/A | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -16.630 | 5.246 | |||||
| 2021-04-05 | 2021-01-25 | 4/A | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 16.630 | 49 | 43.147 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -4.431 | 132.276 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 25,8551 | -4.431 | -115 | 0 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4.431 | 57 | 4.431 | ||||
| 2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -8.312 | 91.746 | |||||
| 2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 29,4889 | -783 | -23 | 21.517 | ||||
| 2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 28,9031 | -7.529 | -218 | 22.300 | ||||
| 2021-03-02 | 2021-03-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 8.312 | 76 | 29.829 | ||||
| 2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -4.431 | 136.707 | |||||
| 2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 29,4699 | -356 | -10 | 0 | ||||
| 2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 28,9197 | -4.075 | -118 | 356 | ||||
| 2021-03-02 | 2021-03-01 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4.431 | 57 | 4.431 | ||||
| 2021-02-08 | 2021-02-05 | 4 | Weissman James B | DRNA | Common Stock | D | 26,9900 | -7.156 | -193 | 20.904 | ||||
| 2021-02-04 | 2021-02-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -8.312 | 100.058 | |||||
| 2021-02-04 | 2021-02-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,0000 | -8.312 | -208 | 21.517 | ||||
| 2021-02-04 | 2021-02-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 8.312 | 76 | 29.829 | ||||
| 2021-02-04 | 2021-02-02 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -4.431 | 141.138 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 24,0000 | -4.431 | -106 | 0 | ||||
| 2021-02-04 | 2021-02-02 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4.431 | 57 | 4.431 | ||||
| 2021-01-27 | 2021-01-25 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -16.630 | 108.370 | |||||
| 2021-01-27 | 2021-01-25 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,0000 | -21.630 | -541 | 21.517 | ||||
| 2021-01-27 | 2021-01-25 | 4 | Brown Bob D | DRNA | Common Stock | D | 9,0900 | 16.630 | 151 | 43.147 | ||||
| 2021-01-27 | 2021-01-25 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -4.431 | 145.569 | |||||
| 2021-01-27 | 2021-01-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 25,0000 | -6.326 | -158 | 0 | ||||
| 2021-01-27 | 2021-01-25 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 4.431 | 57 | 6.326 | ||||
| 2021-01-13 | 2021-01-12 | 4 | Weissman James B | DRNA | Common Stock | D | 24,0820 | -5.808 | -140 | 28.060 | ||||
| 2021-01-13 | 2021-01-12 | 4 | Brown Bob D | DRNA | Common Stock | D | 24,0732 | -5.808 | -140 | 26.517 | ||||
| 2021-01-12 | 2021-01-12 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 51.070 | 51.070 | |||||
| 2021-01-12 | 2021-01-12 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | 11.350 | 11.350 | ||||||
| 2021-01-12 | 2021-01-12 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 68.100 | 68.100 | |||||
| 2021-01-12 | 2021-01-12 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | 15.100 | 15.100 | ||||||
| 2021-01-12 | 2021-01-11 | 4 | Weissman James B | DRNA | Common Stock | D | 23,9900 | -3.800 | -91 | 33.868 | ||||
| 2021-01-12 | 2021-01-08 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | -8.650 | 25.950 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | Weissman James B | DRNA | Common Stock | D | 23,2900 | -2.842 | -66 | 37.668 | ||||
| 2021-01-12 | 2021-01-08 | 4 | Weissman James B | DRNA | Common Stock | D | 8.650 | 40.510 | ||||||
| 2021-01-12 | 2021-01-12 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 247.700 | 247.700 | |||||
| 2021-01-12 | 2021-01-12 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | 55.000 | 55.000 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | -19.950 | 59.850 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 23,2900 | -6.159 | -143 | 37.030 | ||||
| 2021-01-12 | 2021-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 19.950 | 43.189 | ||||||
| 2021-01-12 | 2021-01-12 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 68.100 | 68.100 | |||||
| 2021-01-12 | 2021-01-12 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | 15.100 | 15.100 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | -8.650 | 25.950 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | Brown Bob D | DRNA | Common Stock | D | 23,2900 | -2.842 | -66 | 32.325 | ||||
| 2021-01-12 | 2021-01-08 | 4 | Brown Bob D | DRNA | Common Stock | D | 8.650 | 35.167 | ||||||
| 2021-01-12 | 2021-01-12 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 46.120 | 46.120 | |||||
| 2021-01-12 | 2021-01-12 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | 10.250 | 10.250 | ||||||
| 2021-01-12 | 2021-01-12 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 36.900 | 36.900 | |||||
| 2021-01-12 | 2021-01-12 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | 8.200 | 8.200 | ||||||
| 2021-01-12 | 2021-01-12 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 61.500 | 61.500 | |||||
| 2021-01-12 | 2021-01-12 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | 13.700 | 13.700 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | -2.900 | 8.700 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 23,2900 | -1.005 | -23 | 1.895 | ||||
| 2021-01-12 | 2021-01-08 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 2.900 | 2.900 | ||||||
| 2021-01-12 | 2021-01-12 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 24,05 | 61.500 | 61.500 | |||||
| 2021-01-12 | 2021-01-12 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | 13.700 | 13.700 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | -5.775 | 17.325 | ||||||
| 2021-01-12 | 2021-01-08 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 23,2900 | -2.002 | -47 | 3.773 | ||||
| 2021-01-12 | 2021-01-08 | 4 | Ciappenelli Robert D. | DRNA | Common Stock | D | 5.775 | 5.775 | ||||||
| 2020-12-14 | 2020-12-10 | 4 | Koppel Adam See footnotes | DRNA | Common Stock | I | 23,4000 | -1.000.000 | -23.400 | 3.080.237 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 0 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,1931 | -8.185 | -206 | 26.517 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 34.702 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -4.360 | 0 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Weissman James B | DRNA | Common Stock | D | 25,2071 | -4.360 | -110 | 31.860 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 4.360 | 15 | 36.220 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 12,93 | -30.000 | 150.000 | |||||
| 2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 23,2500 | -15.000 | -349 | 0 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 22,2500 | -15.000 | -334 | 15.000 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Paglia Regina M. | DRNA | Common Stock | D | 12,9300 | 30.000 | 388 | 30.000 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 8.185 | |||||
| 2020-11-03 | 2020-11-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0300 | -8.185 | -172 | 26.517 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 34.702 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -4.360 | 4.360 | |||||
| 2020-11-03 | 2020-11-02 | 4 | Weissman James B | DRNA | Common Stock | D | 20,9480 | -4.360 | -91 | 31.860 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 4.360 | 15 | 36.220 | ||||
| 2020-10-22 | 2020-10-20 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -10.000 | 11.879 | |||||
| 2020-10-22 | 2020-10-20 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 10.000 | 30 | 31.860 | ||||
| 2020-10-20 | 2020-10-16 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -16.370 | 16.370 | |||||
| 2020-10-20 | 2020-10-16 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | -16.370 | -344 | 26.517 | ||||
| 2020-10-20 | 2020-10-16 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 16.370 | 56 | 42.887 | ||||
| 2020-10-19 | 2020-10-15 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.720 | 8.720 | |||||
| 2020-10-19 | 2020-10-15 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | -8.720 | -176 | 21.860 | ||||
| 2020-10-19 | 2020-10-15 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 8.720 | 30 | 30.580 | ||||
| 2020-10-02 | 2020-10-01 | 4 | Aradhye Shreeram | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | 124.700 | 124.700 | |||||
| 2020-10-02 | 2020-10-01 | 4 | Aradhye Shreeram | DRNA | Restricted Stock Units | D | 28.100 | 28.100 | ||||||
| 2020-10-02 | 2020-10-01 | 4 | Zeng Ling | DRNA | Employee Stock Option (Right to Buy) | D | 18,69 | 81.825 | 81.825 | |||||
| 2020-10-02 | 2020-10-01 | 4 | Zeng Ling | DRNA | Restricted Stock Units | D | 18.225 | 18.225 | ||||||
| 2020-09-18 | 2020-09-16 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -21.250 | 77.874 | |||||
| 2020-09-18 | 2020-09-16 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 21.250 | 73 | 26.517 | ||||
| 2020-09-16 | 2020-09-14 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -267 | 0 | |||||
| 2020-09-16 | 2020-09-14 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 267 | 1 | 5.267 | ||||
| 2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.360 | 25.980 | |||||
| 2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Common Stock | D | 26,8678 | -1.307 | -35 | 21.860 | ||||
| 2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Common Stock | D | 26,3881 | -3.053 | -81 | 23.167 | ||||
| 2020-09-04 | 2020-07-01 | 4/A | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.360 | 13 | 26.220 | ||||
| 2020-09-01 | 2020-09-01 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 18,0597 | 10.000 | 181 | 22.300 | ||||
| 2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 32.740 | |||||
| 2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,7999 | -2.521 | -57 | 5.000 | ||||
| 2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,3355 | -5.664 | -127 | 7.521 | ||||
| 2020-08-05 | 2020-08-03 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 13.185 | ||||
| 2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -259 | 17.440 | |||||
| 2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.101 | 21.879 | |||||
| 2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 22,7993 | -1.432 | -33 | 21.860 | ||||
| 2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 22,3120 | -2.928 | -65 | 23.292 | ||||
| 2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 259 | 1 | 26.220 | ||||
| 2020-08-05 | 2020-08-03 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.101 | 12 | 25.961 | ||||
| 2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.360 | 25.980 | |||||
| 2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Common Stock | D | 26,8678 | -1.307 | -35 | 21.860 | ||||
| 2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Common Stock | D | 26,3881 | -3.053 | -81 | 23.167 | ||||
| 2020-07-06 | 2020-07-01 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.360 | 13 | 26.220 | ||||
| 2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 40.925 | |||||
| 2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 26,8533 | -2.371 | -64 | 5.000 | ||||
| 2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 26,3604 | -5.814 | -153 | 7.371 | ||||
| 2020-07-06 | 2020-07-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 13.185 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Paglia Regina M. | DRNA | Employee Stock Option (Right to Buy) | D | 26,62 | 6.825 | 6.825 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Paglia Regina M. | DRNA | Restricted Stock Units | D | 1.525 | 1.525 | ||||||
| 2020-06-23 | 2020-06-19 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -9.670 | 21.876 | |||||
| 2020-06-23 | 2020-06-19 | 4 | Brown Bob D | DRNA | Common Stock | D | 25,0000 | -9.670 | -242 | 5.000 | ||||
| 2020-06-23 | 2020-06-19 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 9.670 | 29 | 14.670 | ||||
| 2020-06-16 | 2020-06-15 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | HOFFMAN STEPHEN J | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Koppel Adam | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | Koppel Adam | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | GRAY PATRICK M. | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | Doberstein Stephen K | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 21.000 | 21.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | BUCHI J KEVIN | DRNA | Restricted Stock Units | D | 4.666 | 4.666 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | Smith Cynthia | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Protopapas Anna | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | Protopapas Anna | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | KOZIN MARC D | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-16 | 2020-06-15 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 21,61 | 15.000 | 15.000 | |||||
| 2020-06-16 | 2020-06-15 | 4 | Freed Martin I | DRNA | Restricted Stock Units | D | 3.333 | 3.333 | ||||||
| 2020-06-02 | 2020-06-01 | 4 | Pagan Douglas W. | DRNA | Employee Stock Option (Right to Buy) | D | 20,79 | 95.650 | 95.650 | |||||
| 2020-06-02 | 2020-06-01 | 4 | Pagan Douglas W. | DRNA | Restricted Stock Units | D | 27.300 | 27.300 | ||||||
| 2020-06-02 | 2020-06-01 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 49.110 | |||||
| 2020-06-02 | 2020-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0091 | -8.185 | -172 | 5.000 | ||||
| 2020-06-02 | 2020-06-01 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 13.185 | ||||
| 2020-06-02 | 2020-06-01 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.360 | 30.340 | |||||
| 2020-06-02 | 2020-06-01 | 4 | Weissman James B | DRNA | Common Stock | D | 21,0567 | -4.360 | -92 | 21.860 | ||||
| 2020-06-02 | 2020-06-01 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.360 | 13 | 26.220 | ||||
| 2020-05-12 | 2020-05-11 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -13.281 | 31.546 | |||||
| 2020-05-12 | 2020-05-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 24,0000 | -13.281 | -319 | 5.000 | ||||
| 2020-05-12 | 2020-05-11 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 13.281 | 39 | 18.281 | ||||
| 2020-05-07 | 2020-05-05 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 57.295 | |||||
| 2020-05-07 | 2020-05-05 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | -8.185 | -172 | 5.000 | ||||
| 2020-05-07 | 2020-05-05 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 13.185 | ||||
| 2020-05-06 | 2020-05-04 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 4.360 | 34.700 | |||||
| 2020-05-06 | 2020-05-04 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | -4.360 | -88 | 21.860 | ||||
| 2020-05-06 | 2020-05-04 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.360 | 13 | 26.220 | ||||
| 2020-04-22 | 2020-04-20 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | -25.624 | 186.375 | |||||
| 2020-04-22 | 2020-04-20 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 22,9500 | -25.624 | -588 | 19.421 | ||||
| 2020-04-22 | 2020-04-20 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 25.624 | 140 | 45.045 | ||||
| 2020-04-21 | 2020-04-20 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -13.281 | 44.827 | |||||
| 2020-04-21 | 2020-04-20 | 4 | Brown Bob D | DRNA | Common Stock | D | 23,0000 | -13.281 | -305 | 5.000 | ||||
| 2020-04-21 | 2020-04-20 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 13.281 | 39 | 18.281 | ||||
| 2020-04-21 | 2020-04-17 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 65.480 | |||||
| 2020-04-21 | 2020-04-17 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,1800 | -8.185 | -173 | 5.000 | ||||
| 2020-04-21 | 2020-04-17 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 13.185 | ||||
| 2020-04-14 | 2020-04-13 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.360 | 39.060 | |||||
| 2020-04-14 | 2020-04-13 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | -4.360 | -88 | 21.860 | ||||
| 2020-04-14 | 2020-04-13 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.360 | 13 | 26.220 | ||||
| 2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -12.968 | 14.063 | |||||
| 2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | -7.501 | 211.999 | |||||
| 2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 19,9500 | -20.469 | -408 | 19.421 | ||||
| 2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 2,9700 | 12.968 | 39 | 39.890 | ||||
| 2020-04-09 | 2020-04-07 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 7.501 | 41 | 26.922 | ||||
| 2020-03-16 | 2020-03-12 | 4 | Doberstein Stephen K | DRNA | Director Stock Option (Right to Buy) | D | 15,61 | 25.000 | 25.000 | |||||
| 2020-03-03 | 2020-03-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.360 | 43.420 | |||||
| 2020-03-03 | 2020-03-02 | 4 | Weissman James B | DRNA | Common Stock | D | 20,6087 | -4.360 | -90 | 21.860 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.360 | 13 | 26.220 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 73.665 | |||||
| 2020-03-03 | 2020-03-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | -8.185 | -172 | 5.000 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 13.185 | ||||
| 2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -2.535 | 99.124 | |||||
| 2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -5.650 | 81.850 | |||||
| 2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,0000 | -8.185 | -172 | 5.000 | ||||
| 2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 2.535 | 9 | 13.185 | ||||
| 2020-02-11 | 2020-02-10 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 5.650 | 19 | 10.650 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.360 | 47.780 | |||||
| 2020-02-04 | 2020-02-03 | 4 | Weissman James B | DRNA | Common Stock | D | 20,2000 | -4.360 | -88 | 21.860 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 4.360 | 13 | 26.220 | ||||
| 2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -20.469 | 27.031 | |||||
| 2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -27.500 | 47.500 | |||||
| 2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 21,2628 | -20.469 | -435 | 19.421 | ||||
| 2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 21,2704 | -27.500 | -585 | 39.890 | ||||
| 2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 2,9700 | 20.469 | 61 | 67.390 | ||||
| 2020-01-21 | 2020-01-17 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 2,9700 | 27.500 | 82 | 46.921 | ||||
| 2020-01-10 | 2020-01-08 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 85.000 | 85.000 | |||||
| 2020-01-10 | 2020-01-08 | 4 | GREEN JOHN B | DRNA | Restricted Stock Units | D | 23.100 | 23.100 | ||||||
| 2020-01-10 | 2020-01-08 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 85.000 | 85.000 | |||||
| 2020-01-10 | 2020-01-08 | 4 | Ciappenelli Robert D. | DRNA | Restricted Stock Units | D | 23.100 | 23.100 | ||||||
| 2020-01-10 | 2020-01-08 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 121.300 | 121.300 | |||||
| 2020-01-10 | 2020-01-08 | 4 | Weissman James B | DRNA | Restricted Stock Units | D | 34.600 | 34.600 | ||||||
| 2020-01-10 | 2020-01-08 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 85.000 | 85.000 | |||||
| 2020-01-10 | 2020-01-08 | 4 | ROSSKAMP RALF | DRNA | Restricted Stock Units | D | 23.100 | 23.100 | ||||||
| 2020-01-10 | 2020-01-08 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 121.300 | 121.300 | |||||
| 2020-01-10 | 2020-01-08 | 4 | Brown Bob D | DRNA | Restricted Stock Units | D | 34.600 | 34.600 | ||||||
| 2020-01-10 | 2020-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 22,58 | 250.000 | 250.000 | |||||
| 2020-01-10 | 2020-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Restricted Stock Units | D | 79.800 | 79.800 | ||||||
| 2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -2.860 | 52.140 | |||||
| 2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -1.500 | 0 | |||||
| 2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Common Stock | D | 21,8753 | -4.360 | -95 | 21.860 | ||||
| 2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 2.860 | 8 | 26.220 | ||||
| 2020-01-03 | 2020-01-02 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 1.500 | 5 | 23.360 | ||||
| 2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -11.941 | 58.108 | |||||
| 2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -5.000 | 101.659 | |||||
| 2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,0000 | -11.941 | -263 | 5.000 | ||||
| 2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 11.941 | 35 | 16.941 | ||||
| 2019-12-31 | 2019-12-31 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 5.000 | 17 | 5.000 | ||||
| 2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -4.951 | 70.049 | |||||
| 2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -8.185 | 106.659 | |||||
| 2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 22,0051 | -1.340 | -29 | 0 | ||||
| 2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 21,8445 | -21.466 | -469 | 1.340 | ||||
| 2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 2,9700 | 4.951 | 15 | 22.806 | ||||
| 2019-12-31 | 2019-12-30 | 4 | Brown Bob D | DRNA | Common Stock | D | 3,4200 | 8.185 | 28 | 17.855 | ||||
| 2019-12-27 | 2019-12-26 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 2,91 | -20.000 | 230.000 | |||||
| 2019-12-27 | 2019-12-26 | 4 | ROSSKAMP RALF | DRNA | Common Stock | D | 22,6882 | -20.000 | -454 | 3.564 | ||||
| 2019-12-27 | 2019-12-26 | 4 | ROSSKAMP RALF | DRNA | Common Stock | D | 2,9100 | 20.000 | 58 | 23.564 | ||||
| 2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -80.000 | 201.250 | |||||
| 2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 27,0735 | -1.431 | -39 | 12.300 | ||||
| 2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 25,8479 | -78.569 | -2.031 | 13.731 | ||||
| 2019-12-19 | 2019-12-18 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 80.000 | 274 | 92.300 | ||||
| 2019-12-19 | 2019-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 26,9443 | -2.305 | -62 | 12.300 | ||||
| 2019-12-19 | 2019-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 26,1344 | -56.716 | -1.482 | 14.605 | ||||
| 2019-12-19 | 2019-12-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -11.001 | 63.999 | |||||
| 2019-12-19 | 2019-12-18 | 4 | Weissman James B | DRNA | Common Stock | D | 26,0100 | -3.845 | -100 | 21.860 | ||||
| 2019-12-19 | 2019-12-18 | 4 | Weissman James B | DRNA | Common Stock | D | 9,0900 | 11.001 | 100 | 25.705 | ||||
| 2019-12-11 | 2019-12-11 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | -8.000 | 219.500 | |||||
| 2019-12-11 | 2019-12-11 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 8.000 | 44 | 18.698 | ||||
| 2019-12-06 | 2019-12-04 | 4 | Koppel Adam See footnotes | DRNA | Common Stock | I | 24,6800 | -1.500.000 | -37.020 | 4.080.237 | ||||
| 2019-12-03 | 2019-12-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | -20.000 | 55.000 | |||||
| 2019-12-03 | 2019-12-02 | 4 | Weissman James B | DRNA | Common Stock | D | 26,0000 | -20.000 | -520 | 14.704 | ||||
| 2019-12-03 | 2019-12-02 | 4 | Weissman James B | DRNA | Common Stock | D | 2,9700 | 20.000 | 59 | 34.704 | ||||
| 2019-12-02 | 2019-12-02 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,9835 | -137.176 | -3.427 | 0 | ||||
| 2019-12-02 | 2019-11-29 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,2154 | -138.000 | -3.342 | 137.176 | ||||
| 2019-12-02 | 2019-11-27 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,0433 | -368.700 | -8.865 | 275.176 | ||||
| 2019-11-27 | 2019-11-25 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | -12.500 | 227.500 | |||||
| 2019-11-27 | 2019-11-25 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 24,9500 | -12.500 | -312 | 10.698 | ||||
| 2019-11-27 | 2019-11-25 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 12.500 | 68 | 23.198 | ||||
| 2019-11-26 | 2019-11-26 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 23,5855 | -239.700 | -5.653 | 643.876 | ||||
| 2019-11-26 | 2019-11-25 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 24,0578 | -361.200 | -8.690 | 883.576 | ||||
| 2019-11-26 | 2019-11-22 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 22,5164 | -197.700 | -4.451 | 1.244.776 | ||||
| 2019-11-21 | 2019-11-19 | 4 | Bain Capital Life Sciences Investors, LLC See Footnotes | DRNA | Common Stock | I | 22,0300 | -1.750.000 | -38.552 | 5.580.237 | ||||
| 2019-11-21 | 2019-11-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 22,9782 | -351.505 | -8.077 | 1.442.476 | ||||
| 2019-11-21 | 2019-11-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 22,9332 | -265.505 | -6.089 | 1.793.981 | ||||
| 2019-11-21 | 2019-11-19 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 23,9217 | -397.183 | -9.501 | 2.059.486 | ||||
| 2019-11-20 | 2019-11-18 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | -12.500 | 240.000 | |||||
| 2019-11-20 | 2019-11-18 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 21,0500 | -12.500 | -263 | 10.698 | ||||
| 2019-11-20 | 2019-11-18 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 12.500 | 68 | 23.198 | ||||
| 2019-11-20 | 2019-11-19 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -20.000 | 0 | |||||
| 2019-11-20 | 2019-11-19 | 4 | Weissman James B | DRNA | Common Stock | D | 24,0000 | -20.000 | -480 | 14.704 | ||||
| 2019-11-20 | 2019-11-19 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 20.000 | 68 | 34.704 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -20.000 | 20.000 | |||||
| 2019-11-20 | 2019-11-18 | 4 | Weissman James B | DRNA | Common Stock | D | 22,0000 | -20.000 | -440 | 14.704 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 20.000 | 68 | 34.704 | ||||
| 2019-11-15 | 2019-11-14 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 20,0000 | -3.562 | -71 | 10.698 | ||||
| 2019-11-15 | 2019-11-14 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -20.000 | 40.000 | |||||
| 2019-11-15 | 2019-11-14 | 4 | Weissman James B | DRNA | Common Stock | D | 20,0000 | -20.000 | -400 | 14.704 | ||||
| 2019-11-15 | 2019-11-14 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 20.000 | 68 | 34.704 | ||||
| 2019-11-01 | 2019-10-31 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -15.000 | 17.699 | |||||
| 2019-11-01 | 2019-10-31 | 4 | Weissman James B | DRNA | Common Stock | D | 18,0000 | -15.000 | -270 | 14.704 | ||||
| 2019-11-01 | 2019-10-31 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 15.000 | 51 | 29.704 | ||||
| 2019-11-01 | 2019-10-31 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | -12.500 | 252.500 | |||||
| 2019-11-01 | 2019-10-31 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 18,0000 | -12.500 | -225 | 14.260 | ||||
| 2019-11-01 | 2019-10-31 | 4 | GREEN JOHN B | DRNA | Common Stock | D | 5,4500 | 12.500 | 68 | 26.760 | ||||
| 2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -4.104 | 60.000 | |||||
| 2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -800 | 0 | |||||
| 2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 4.104 | 14 | 14.704 | ||||
| 2019-10-18 | 2019-10-18 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 800 | 3 | 10.600 | ||||
| 2019-09-19 | 2019-09-17 | 4 | GRAY PATRICK M. | DRNA | Director Stock Option (Right to Buy) | D | 14,32 | 25.000 | 25.000 | |||||
| 2019-08-23 | 2019-08-23 | 4 | Weissman James B | DRNA | Common Stock | D | 13,0676 | -14.680 | -192 | 9.800 | ||||
| 2019-07-01 | 2019-07-01 | 4 | Ciappenelli Robert D. | DRNA | Employee Stock Option (Right to Buy) | D | 15,61 | 300.000 | 300.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Smith Cynthia | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Freed Martin I | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (right to buy) | D | 15,44 | 33.000 | 33.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Protopapas Anna | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | Koppel Adam | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-06-21 | 2019-06-20 | 4 | KOZIN MARC D | DRNA | Director Stock Option (right to buy) | D | 15,44 | 25.000 | 25.000 | |||||
| 2019-05-31 | 2019-05-29 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 12,5000 | -1.600.000 | -20.000 | 7.330.237 | ||||
| 2019-04-04 | 2019-04-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -15.000 | 32.699 | |||||
| 2019-04-04 | 2019-04-02 | 4 | Weissman James B | DRNA | Common Stock | D | 15,0000 | -15.000 | -225 | 24.480 | ||||
| 2019-04-04 | 2019-04-02 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 15.000 | 51 | 39.480 | ||||
| 2019-03-29 | 2019-03-28 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,13 | 8.000 | 8.000 | |||||
| 2019-01-25 | 2019-01-23 | 4 | KOZIN MARC D | DRNA | Director Stock Option (Right to Buy) | D | 10,31 | 25.000 | 25.000 | |||||
| 2019-01-25 | 2019-01-23 | 4 | Protopapas Anna | DRNA | Director Stock Option (Right to Buy) | D | 10,31 | 25.000 | 25.000 | |||||
| 2019-01-25 | 3 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 10.000 | ||||||||
| 2019-01-25 | 3 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 10.000 | ||||||||
| 2019-01-25 | 3 | KOZIN MARC D By Marc D. Kozin Revocable Trust | DRNA | Common Stock | I | 10.000 | ||||||||
| 2019-01-04 | 2019-01-02 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180.000 | 180.000 | |||||
| 2019-01-04 | 2019-01-02 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 505.000 | 505.000 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180.000 | 180.000 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180.000 | 180.000 | |||||
| 2019-01-04 | 2019-01-02 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 11,77 | 180.000 | 180.000 | |||||
| 2018-11-09 | 2018-11-08 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 14,8599 | -107.920 | -1.604 | 2.456.669 | ||||
| 2018-11-09 | 2018-11-07 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 14,7402 | -250.000 | -3.685 | 2.564.589 | ||||
| 2018-11-06 | 2018-11-06 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,8434 | -263.300 | -3.645 | 2.814.589 | ||||
| 2018-11-06 | 2018-11-05 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 12,8880 | -71.400 | -920 | 3.077.889 | ||||
| 2018-11-06 | 2018-11-02 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,4926 | -175.700 | -2.371 | 3.149.289 | ||||
| 2018-11-06 | 2018-11-06 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,1600 | -11 | -0 | 19.150 | ||||
| 2018-11-06 | 2018-11-06 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,1600 | -1.489 | -21 | 2.586.535 | ||||
| 2018-11-06 | 2018-11-06 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,1800 | -761 | -10 | 19.161 | ||||
| 2018-11-06 | 2018-11-06 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,1800 | -102.067 | -1.345 | 2.588.024 | ||||
| 2018-11-06 | 2018-11-05 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 12,9800 | -295 | -4 | 19.922 | ||||
| 2018-11-06 | 2018-11-05 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 12,9800 | -39.606 | -514 | 2.690.091 | ||||
| 2018-11-06 | 2018-11-02 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,4700 | -1.412 | -19 | 20.217 | ||||
| 2018-11-06 | 2018-11-02 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,4700 | -189.359 | -2.551 | 2.729.697 | ||||
| 2018-11-05 | 2018-11-01 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,3700 | -1.408 | -19 | 21.629 | ||||
| 2018-11-05 | 2018-11-01 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,3700 | -188.867 | -2.525 | 2.919.056 | ||||
| 2018-11-05 | 2018-10-31 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6000 | -959 | -13 | 23.037 | ||||
| 2018-11-05 | 2018-10-31 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6000 | -128.670 | -1.750 | 3.107.923 | ||||
| 2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,3100 | -678 | -10 | 23.996 | ||||
| 2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,3100 | -90.918 | -1.301 | 3.236.593 | ||||
| 2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6800 | -1.136 | -16 | 24.674 | ||||
| 2018-11-05 | 2018-10-30 | 4/A | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6800 | -152.364 | -2.084 | 3.327.511 | ||||
| 2018-11-01 | 2018-11-01 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,3757 | -180.100 | -2.409 | 3.324.989 | ||||
| 2018-11-01 | 2018-10-31 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,4619 | -178.400 | -2.402 | 3.505.089 | ||||
| 2018-11-01 | 2018-10-30 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 13,8603 | -250.000 | -3.465 | 3.683.489 | ||||
| 2018-11-01 | 2018-11-01 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,3700 | -1.408 | -19 | 21.629 | ||||
| 2018-11-01 | 2018-11-01 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,3700 | -188.167 | -2.516 | 2.919.056 | ||||
| 2018-11-01 | 2018-10-31 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6000 | -959 | -13 | 23.037 | ||||
| 2018-11-01 | 2018-10-31 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6000 | -128.670 | -1.750 | 3.107.923 | ||||
| 2018-11-01 | 2018-10-30 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,3100 | -678 | -10 | 23.996 | ||||
| 2018-11-01 | 2018-10-30 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,3100 | -90.918 | -1.301 | 3.236.593 | ||||
| 2018-11-01 | 2018-10-30 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13,6800 | -1.136 | -16 | 24.674 | ||||
| 2018-11-01 | 2018-10-30 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 13,6800 | -152.364 | -2.084 | 3.327.511 | ||||
| 2018-09-06 | 2018-09-05 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -2.301 | 47.699 | |||||
| 2018-09-06 | 2018-09-05 | 4 | Weissman James B | DRNA | Common Stock | D | 17,5000 | -2.301 | -40 | 24.480 | ||||
| 2018-09-06 | 2018-09-05 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 2.301 | 8 | 26.781 | ||||
| 2018-08-20 | 2018-08-17 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -14.680 | 64.104 | |||||
| 2018-08-20 | 2018-08-17 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 14.680 | 50 | 24.480 | ||||
| 2018-08-17 | 2018-08-15 | 4 | LANGER DENNIS | DRNA | Common Stock | D | 16,0000 | -14.531 | -232 | 29.064 | ||||
| 2018-08-17 | 2018-08-15 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 16,0000 | -23.810 | -381 | 47.978 | ||||
| 2018-08-15 | 2018-08-13 | 4 | Smith Cynthia | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | 25.000 | 25.000 | |||||
| 2018-08-15 | 2018-08-13 | 4 | BUCHI J KEVIN | DRNA | Director Stock Option (Right to Buy) | D | 14,76 | 25.000 | 25.000 | |||||
| 2018-06-26 | 2018-06-21 | 4 | Wise Bart W | DRNA | Employee Stock Option (Right to Buy) | D | 13,08 | 25.000 | 25.000 | |||||
| 2018-06-26 | 3 | Wise Bart W | DRNA | Common Stock | D | 11.294 | ||||||||
| 2018-06-26 | 3 | Wise Bart W | DRNA | Common Stock | D | 11.294 | ||||||||
| 2018-06-26 | 3 | Wise Bart W | DRNA | Common Stock | D | 11.294 | ||||||||
| 2018-06-25 | 2018-06-21 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 13,08 | 25.000 | 25.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25.000 | 25.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25.000 | 25.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25.000 | 25.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 13,08 | 33.000 | 33.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 13,08 | 25.000 | 25.000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Koppel Adam | DRNA | Director Stock Option (right to buy) | D | 13,08 | 25.000 | 25.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Warrant to Purchase Common Stock | I | 7,00 | -156 | 0 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Warrant to Purchase Common Stock | I | 7,00 | -21.041 | 0 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 14,4500 | -76 | -1 | 25.810 | ||||
| 2018-06-11 | 2018-06-07 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 14,4500 | -10.195 | -147 | 3.479.875 | ||||
| 2018-06-11 | 2018-06-07 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 7,0000 | 156 | 1 | 25.886 | ||||
| 2018-06-11 | 2018-06-07 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 7,0000 | 21.041 | 147 | 3.490.070 | ||||
| 2018-05-11 | 2018-05-09 | 4 | Brown Bob D | DRNA | Common Stock | D | 15,0000 | -9.669 | -145 | 9.670 | ||||
| 2018-05-11 | 2018-05-09 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -10.000 | 50.000 | |||||
| 2018-05-11 | 2018-05-09 | 4 | Weissman James B | DRNA | Common Stock | D | 15,0000 | -10.000 | -150 | 9.800 | ||||
| 2018-05-11 | 2018-05-09 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 10.000 | 34 | 19.800 | ||||
| 2018-04-24 | 2018-04-20 | 4 | Weissman James B | DRNA | Common Stock | D | 13,0000 | -8.965 | -117 | 9.800 | ||||
| 2018-03-27 | 2018-03-23 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,0511 | -55.300 | -611 | 3.933.489 | ||||
| 2018-03-21 | 2018-03-19 | 4 | Weissman James B | DRNA | Common Stock | D | 13,0000 | -1.035 | -13 | 18.765 | ||||
| 2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1727 | -36.224 | -405 | 3.988.789 | ||||
| 2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1400 | -49.000 | -546 | 4.025.013 | ||||
| 2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,0718 | -31.145 | -345 | 4.074.013 | ||||
| 2018-03-21 | 2018-03-21 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,2399 | -64.600 | -726 | 4.105.158 | ||||
| 2018-03-21 | 2018-03-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1648 | -67.985 | -759 | 4.169.758 | ||||
| 2018-03-21 | 2018-03-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,1555 | -55.200 | -616 | 4.237.743 | ||||
| 2018-03-21 | 2018-03-20 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 11,0000 | -50.000 | -550 | 4.292.943 | ||||
| 2018-03-21 | 2018-03-19 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 12,4550 | -34.700 | -432 | 4.342.943 | ||||
| 2018-03-21 | 2018-03-19 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 12,6308 | -84.670 | -1.069 | 4.377.643 | ||||
| 2018-01-30 | 2018-01-26 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Stock Option (Right to Buy) | I | 3,42 | -360 | 0 | |||||
| 2018-01-30 | 2018-01-26 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 3,4200 | 360 | 1 | 71.788 | ||||
| 2018-01-19 | 2018-01-18 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,2271 | -59.700 | -551 | 4.462.313 | ||||
| 2018-01-19 | 2018-01-17 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,3254 | -220.900 | -2.060 | 4.522.013 | ||||
| 2018-01-08 | 2018-01-04 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 105.000 | 105.000 | |||||
| 2018-01-08 | 2018-01-04 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 255.000 | 255.000 | |||||
| 2018-01-08 | 2018-01-04 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 105.000 | 105.000 | |||||
| 2018-01-08 | 2018-01-04 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 105.000 | 105.000 | |||||
| 2018-01-08 | 2018-01-04 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 9,30 | 57.750 | 57.750 | |||||
| 2018-01-08 | 2018-01-05 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1461 | -18.100 | -166 | 4.742.913 | ||||
| 2018-01-08 | 2018-01-04 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1978 | -77.400 | -712 | 4.761.013 | ||||
| 2018-01-03 | 2018-01-03 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,2533 | -59.100 | -547 | 4.838.413 | ||||
| 2018-01-03 | 2018-01-02 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,4655 | -68.000 | -644 | 4.897.513 | ||||
| 2018-01-03 | 2017-12-29 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1288 | -23.100 | -211 | 4.965.513 | ||||
| 2018-01-03 | 2017-12-29 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 9,1026 | -85.400 | -777 | 4.988.613 | ||||
| 2017-12-20 | 2017-12-18 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | DRNA | Redeemable Convertible Preferred Stock | I | 3,1900 | -76.500 | -244 | 0 | ||||
| 2017-12-20 | 2017-12-18 | 4 | RA CAPITAL MANAGEMENT, LLC See Note | DRNA | Common Stock | I | 2.645.442 | 5.074.013 | ||||||
| 2017-12-20 | 2017-12-18 | 4 | Kolchinsky Peter See Note | DRNA | Redeemable Convertible Preferred Stock | I | 3,1900 | -76.500 | -244 | 0 | ||||
| 2017-12-20 | 2017-12-18 | 4 | Kolchinsky Peter See Note | DRNA | Common Stock | I | 2.645.442 | 5.074.013 | ||||||
| 2017-12-20 | 2017-12-18 | 4 | Domain Partners VIII, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | -49.632 | 0 | |||||
| 2017-12-20 | 2017-12-18 | 4 | Domain Partners VIII, L.P. | DRNA | Common Stock | D | 37.890 | 3.469.029 | ||||||
| 2017-12-20 | 2017-12-18 | 4 | Domain Partners VIII, L.P. | DRNA | Common Stock | D | 3,1900 | 1.678.432 | 5.354 | 3.431.139 | ||||
| 2017-12-20 | 2017-12-18 | 4 | DP VIII Associates, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | -368 | 0 | |||||
| 2017-12-20 | 2017-12-18 | 4 | DP VIII Associates, L.P. | DRNA | Common Stock | D | 282 | 25.730 | ||||||
| 2017-12-20 | 2017-12-18 | 4 | DP VIII Associates, L.P. | DRNA | Common Stock | D | 3,1900 | 12.444 | 40 | 25.448 | ||||
| 2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Redeemable Convertible Preferred Stock | I | 3,1900 | -250.000 | -798 | 0 | ||||
| 2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 190.849 | 8.930.237 | ||||||
| 2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 8.454.388 | 8.739.388 | ||||||
| 2017-12-19 | 2017-12-18 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | DRNA | Common Stock | I | 7,0000 | 285.000 | 1.995 | 285.000 | ||||
| 2017-07-24 | 2017-07-18 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25.000 | 25.000 | |||||
| 2017-07-20 | 2017-07-18 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25.000 | 25.000 | |||||
| 2017-07-20 | 2017-07-18 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25.000 | 25.000 | |||||
| 2017-07-20 | 2017-07-18 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25.000 | 25.000 | |||||
| 2017-07-20 | 2017-07-18 | 4 | Freed Martin I | DRNA | Director Stock Option (Right to Buy) | D | 3,42 | 25.000 | 25.000 | |||||
| 2017-07-20 | 2017-07-18 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 3,42 | 33.000 | 33.000 | |||||
| 2017-07-20 | 2017-07-18 | 4 | Koppel Adam | DRNA | Director Stock Option (right to buy) | D | 3,42 | 25.000 | 25.000 | |||||
| 2017-07-20 | 2017-07-18 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 3,42 | 25.000 | 25.000 | |||||
| 2017-06-16 | 2017-06-15 | 4 | ROSSKAMP RALF | DRNA | Employee Stock Option (Right to Buy) | D | 2,91 | 250.000 | 250.000 | |||||
| 2017-04-13 | 2017-04-11 | 4 | Koppel Adam | DRNA | Employee Stock Option (Right to buy) | D | 3,47 | 25.000 | 25.000 | |||||
| 2017-04-13 | 2017-04-11 | 4 | RA CAPITAL MANAGEMENT, LLC See Note 1 | DRNA | Redeemable Convertible Preferred Stock | I | 3,19 | 100,0000 | 76.500 | 7.650 | 76.500 | |||
| 2017-04-12 | 2017-04-11 | 4 | DP VIII Associates, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | 100,0000 | 368 | 37 | 368 | |||
| 2017-04-12 | 2017-04-11 | 4 | Domain Partners VIII, L.P. | DRNA | Redeemable Convertible Preferred Stock | D | 3,19 | 100,0000 | 49.632 | 4.963 | 49.632 | |||
| 2017-01-05 | 2017-01-03 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 75.000 | 75.000 | |||||
| 2017-01-05 | 2017-01-03 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 225.000 | 225.000 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy | D | 2,97 | 75.000 | 75.000 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 2,97 | 75.000 | 75.000 | |||||
| 2016-11-17 | 2016-11-16 | 4 | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 3,5200 | -23.766 | -84 | 71.428 | ||||
| 2016-11-16 | 2016-11-15 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,6300 | 16.500 | 60 | 55.579 | ||||
| 2016-11-16 | 2016-11-14 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,7800 | 16.600 | 63 | 39.079 | ||||
| 2016-06-16 | 2016-06-14 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 3,26 | 15.000 | 15.000 | |||||
| 2016-06-15 | 2016-06-14 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15.000 | 15.000 | |||||
| 2016-06-15 | 2016-06-14 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15.000 | 15.000 | |||||
| 2016-06-15 | 2016-06-14 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15.000 | 15.000 | |||||
| 2016-06-15 | 2016-06-14 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 3,26 | 20.000 | 20.000 | |||||
| 2016-06-15 | 2016-06-14 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 3,26 | 15.000 | 15.000 | |||||
| 2016-06-15 | 2016-06-14 | 4 | Freed Martin I | DRNA | Employee Stock Option (Right to Buy) | D | 3,26 | 25.000 | 25.000 | |||||
| 2016-05-16 | 2016-05-12 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2899 | 4.170 | 14 | 19.800 | ||||
| 2016-05-16 | 2016-05-12 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2897 | 530 | 2 | 15.630 | ||||
| 2016-05-16 | 2016-05-12 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2399 | 300 | 1 | 15.100 | ||||
| 2016-04-18 | 2016-04-14 | 4 | GREEN JOHN B | DRNA | Employee Stock Option (Right to Buy) | D | 5,45 | 265.000 | 265.000 | |||||
| 2016-02-05 | 2016-02-03 | 4 | LANGER DENNIS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -34.722 | 6.945 | |||||
| 2016-02-05 | 2016-02-03 | 4 | LANGER DENNIS | DRNA | Common Stock | D | 3,4200 | 34.722 | 119 | 43.595 | ||||
| 2016-01-12 | 2016-01-08 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 225.000 | 225.000 | |||||
| 2016-01-12 | 2016-01-08 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | -75.000 | 75.000 | |||||
| 2016-01-12 | 2016-01-08 | 4 | Bhargava Pankaj | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 75.000 | 75.000 | |||||
| 2016-01-12 | 2016-01-08 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 75.000 | 75.000 | |||||
| 2016-01-12 | 2016-01-08 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 9,09 | 125.000 | 125.000 | |||||
| 2015-06-29 | 2015-06-25 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 13,87 | 15.000 | 15.000 | |||||
| 2015-06-29 | 2015-06-25 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15.000 | 15.000 | |||||
| 2015-06-29 | 2015-06-25 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15.000 | 15.000 | |||||
| 2015-06-26 | 2015-06-25 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15.000 | 15.000 | |||||
| 2015-06-26 | 2015-06-25 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 13,87 | 20.000 | 20.000 | |||||
| 2015-06-26 | 2015-06-25 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 13,87 | 15.000 | 15.000 | |||||
| 2015-02-24 | 2015-02-20 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 26,0200 | -37.532 | -977 | 1.719.671 | ||||
| 2015-01-13 | 2015-01-09 | 4 | Brown Bob D | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 75.000 | 75.000 | |||||
| 2015-01-13 | 2015-01-09 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 225.000 | 225.000 | |||||
| 2015-01-13 | 2015-01-09 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 3.333 | 3.333 | |||||
| 2015-01-13 | 2015-01-09 | 4 | Dentzer James E | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 75.000 | 75.000 | |||||
| 2015-01-13 | 2015-01-09 | 4 | Bhargava Pankaj | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 56.250 | 56.250 | |||||
| 2015-01-13 | 2015-01-09 | 4 | Weissman James B | DRNA | Employee Stock Option (Right to Buy) | D | 18,50 | 75.000 | 75.000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -1.450 | 0 | |||||
| 2014-12-19 | 2014-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (Right to Buy) | D | 3,42 | -1.050 | 0 | |||||
| 2014-12-19 | 2014-12-17 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 2.500 | 9 | 19.800 | ||||
| 2014-12-16 | 2014-12-15 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 13,08 | 115.000 | 115.000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | Ashburn Theodore | DRNA | Employee Stock Option (Right to Buy) | D | 13,08 | 115.000 | 115.000 | |||||
| 2014-12-16 | 3 | Ashburn Theodore | DRNA | No securities are beneficially owned | D | 0 | ||||||||
| 2014-12-11 | 2014-12-09 | 4 | PEACOCK BRUCE | DRNA | Director Stock Option (right to buy) | D | 11,04 | 25.000 | 25.000 | |||||
| 2014-11-25 | 2014-11-25 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,5000 | -55.035 | -633 | 800.794 | ||||
| 2014-11-25 | 2014-11-25 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,5000 | -48.027 | -552 | 698.822 | ||||
| 2014-11-25 | 2014-11-25 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,5000 | -18.903 | -217 | 275.046 | ||||
| 2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,5400 | -3.785 | -44 | 855.829 | ||||
| 2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,5400 | -3.303 | -38 | 746.849 | ||||
| 2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,5500 | -14.199 | -164 | 293.949 | ||||
| 2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,5500 | -41.339 | -477 | 859.614 | ||||
| 2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,5500 | -36.074 | -417 | 750.152 | ||||
| 2014-11-25 | 2014-11-24 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,5400 | -1.300 | -15 | 308.148 | ||||
| 2014-11-25 | 2014-11-21 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,0000 | -45.124 | -496 | 900.953 | ||||
| 2014-11-25 | 2014-11-21 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,0000 | -39.377 | -433 | 786.226 | ||||
| 2014-11-25 | 2014-11-21 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,0000 | -15.499 | -170 | 309.448 | ||||
| 2014-11-10 | 2014-11-07 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 9,3300 | -30.100 | -281 | 0 | ||||
| 2014-11-10 | 2014-11-07 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 9,2700 | -3.500 | -32 | 30.100 | ||||
| 2014-11-10 | 2014-11-07 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 9,0000 | -180.564 | -1.625 | 33.600 | ||||
| 2014-10-15 | 2014-10-15 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 10,0100 | -51.449 | -515 | 214.164 | ||||
| 2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 11,0200 | -14.464 | -159 | 946.077 | ||||
| 2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 11,0200 | -12.622 | -139 | 825.603 | ||||
| 2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 11,0200 | -4.061 | -45 | 265.613 | ||||
| 2014-10-15 | 2014-10-14 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 11,0200 | -4.968 | -55 | 324.947 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 12,0020 | -246 | -3 | 960.541 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 12,0020 | -215 | -3 | 838.225 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 12,0020 | -69 | -1 | 269.674 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 12,0020 | -84 | -1 | 330 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 12,1350 | -11.855 | -144 | 960.787 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 12,1350 | -10.345 | -126 | 838.440 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 12,1350 | -3.328 | -40 | 269.743 | ||||
| 2014-10-15 | 2014-10-10 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 12,1350 | -4.072 | -49 | 329.999 | ||||
| 2014-06-24 | 2014-06-18 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15.000 | 15.000 | |||||
| 2014-06-23 | 2014-06-18 | 4 | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15.000 | 15.000 | |||||
| 2014-06-23 | 2014-06-18 | 4 | Miles Vincent J | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15.000 | 15.000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 18,73 | 15.000 | 15.000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 18,73 | 20.000 | 20.000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 18,73 | 15.000 | 15.000 | |||||
| 2014-05-08 | 2014-04-16 | 4/A | Kolchinsky Peter | DRNA | Director Stock Option (right to buy) | D | 16,30 | 25.000 | 25.000 | |||||
| 2014-04-30 | 2014-04-16 | 4/A | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 16,30 | 25.000 | 25.000 | |||||
| 2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Series C Preferred | I | -71.428 | 0 | ||||||
| 2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Series B Preferred | I | -8.586 | 0 | ||||||
| 2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Series A Preferred | I | -15.000 | 0 | ||||||
| 2014-04-21 | 2014-02-04 | 4/A | LANGER DENNIS Langer Family Holdings, LLLP | DRNA | Common Stock | I | 95.014 | 95.194 | ||||||
| 2014-04-21 | 2014-04-16 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | DRNA | Director Stock Option (right to buy) | I | 16,30 | 25.000 | 25.000 | |||||
| 2014-04-18 | 2014-04-16 | 4 | Halak Brian K | DRNA | Stock Option (Right to Buy) | D | 16,30 | 25.000 | 25.000 | |||||
| 2014-04-18 | 2014-04-16 | 4 | LANGER DENNIS | DRNA | Director Stock Option (right to buy) | D | 16,30 | 25.000 | 25.000 | |||||
| 2014-04-18 | 2014-04-16 | 4 | HOFFMAN STEPHEN J | DRNA | Director Stock Option (right to buy) | D | 16,30 | 25.000 | 25.000 | |||||
| 2014-04-18 | 2014-04-16 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 471.900 | 471.900 | |||||
| 2014-04-18 | 2014-04-16 | 4 | Miles Vincent J See footnotes | DRNA | Director Stock Option (right to buy | I | 16,30 | 25.000 | 25.000 | |||||
| 2014-04-18 | 2014-04-16 | 4 | MADDEN DAVID | DRNA | Director Stock Option (right to buy) | D | 16,30 | 30.000 | 30.000 | |||||
| 2014-04-18 | 2014-04-16 | 4 | Dentzer James E | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 108.750 | 108.750 | |||||
| 2014-04-18 | 2014-04-16 | 4 | Brown Bob D | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 165.050 | 165.050 | |||||
| 2014-04-18 | 2014-04-16 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 111.800 | 111.800 | |||||
| 2014-04-18 | 2014-04-16 | 4 | Bhargava Pankaj | DRNA | Employee Stock Option (right to buy) | D | 16,30 | 264.808 | 264.808 | |||||
| 2014-04-11 | 2014-03-18 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 38,6200 | -14.937 | -577 | 1.550.862 | ||||
| 2014-04-11 | 2014-03-18 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 37,7500 | -250.000 | -9.438 | 1.565.799 | ||||
| 2014-04-11 | 2014-03-17 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 36,5000 | -9.301 | -339 | 1.815.799 | ||||
| 2014-04-11 | 2014-03-14 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 35,5000 | -200.000 | -7.100 | 1.825.100 | ||||
| 2014-04-11 | 2014-03-14 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 35,3300 | -50.400 | -1.781 | 2.025.100 | ||||
| 2014-04-11 | 2014-03-12 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 37,7700 | -1.500 | -57 | 2.075.500 | ||||
| 2014-04-11 | 2014-03-11 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 38,3700 | -2.900 | -111 | 2.077.000 | ||||
| 2014-04-11 | 2014-03-11 | 4 | Bain Capital Public Equity Management, LLC | DRNA | Common Stock | I | 38,0000 | -257.100 | -9.770 | 2.079.900 | ||||
| 2014-04-03 | 3 | Bhargava Pankaj | DRNA | No securities are beneficially owned | D | 0 | ||||||||
| 2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series C Preferred | I | -71.428 | 0 | ||||||
| 2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series B Preferred | I | -8.586 | 0 | ||||||
| 2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series A Preferred | I | -10.000 | 0 | ||||||
| 2014-02-20 | 2014-01-29 | 4/A | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Common Stock | I | 90.014 | 90.014 | ||||||
| 2014-02-20 | 2014-01-27 | 4/A | LANGER DENNIS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -540 | 0 | |||||
| 2014-02-20 | 2014-01-27 | 4/A | LANGER DENNIS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -8.333 | 41.667 | |||||
| 2014-02-20 | 2014-01-27 | 4/A | LANGER DENNIS | DRNA | Common Stock | D | 3,4200 | 8.873 | 30 | 8.873 | ||||
| 2014-02-20 | 2013-09-24 | 4/A | LANGER DENNIS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 50.000 | 50.000 | |||||
| 2014-02-20 | 2014-01-29 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 15,0000 | 5.000 | 75 | 17.300 | ||||
| 2014-02-20 | 2013-11-11 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -4.350 | 1.450 | |||||
| 2014-02-20 | 2013-11-11 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -4.950 | 1.050 | |||||
| 2014-02-20 | 2013-11-11 | 4 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 3,4200 | 9.300 | 32 | 12.300 | ||||
| 2014-02-20 | 2013-09-24 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 281.250 | 281.250 | |||||
| 2014-02-20 | 2013-09-24 | 4 | FAMBROUGH DOUGLAS | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 281.250 | 281.250 | |||||
| 2014-02-20 | 2014-01-29 | 4 | MADDEN DAVID | DRNA | Common Stock | D | 15,0000 | 7.500 | 112 | 120.011 | ||||
| 2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -110.000 | 0 | |||||
| 2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -1.311 | 0 | |||||
| 2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -1.200 | 0 | |||||
| 2014-02-20 | 2014-01-24 | 4 | MADDEN DAVID | DRNA | Common Stock | D | 3,4200 | 112.511 | 385 | 112.511 | ||||
| 2014-02-20 | 2013-09-24 | 4 | MADDEN DAVID | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 110.000 | 110.000 | |||||
| 2014-02-20 | 2014-01-29 | 4 | Weissman James B | DRNA | Common Stock | D | 15,0000 | 1.000 | 15 | 13.116 | ||||
| 2014-02-20 | 2014-01-27 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -67 | 800 | |||||
| 2014-02-20 | 2014-01-27 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -11.216 | 78.784 | |||||
| 2014-02-20 | 2014-01-27 | 4 | Weissman James B | DRNA | Common Stock | D | 3,2400 | 11.283 | 37 | 12.116 | ||||
| 2014-02-20 | 2013-11-11 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -100 | 1.500 | |||||
| 2014-02-20 | 2013-11-11 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | -733 | 867 | |||||
| 2014-02-20 | 2013-11-05 | 4 | Weissman James B | DRNA | Common Stock | D | 3,4200 | 833 | 3 | 833 | ||||
| 2014-02-20 | 2013-09-24 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 90.000 | 90.000 | |||||
| 2014-02-20 | 2013-09-24 | 4 | Weissman James B | DRNA | Employee Stock Option (right to buy) | D | 3,42 | 60.000 | 60.000 | |||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock Warrant (right to buy) | I | 7,00 | 21.697 | 21.697 | |||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series C Preferred Stock Warrants | I | 7,00 | -21.697 | 0 | |||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock Warrant | I | 250,00 | 755 | 755 | |||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series C Preferred Stock | I | -1.043.429 | 0 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series B Preferred Stock | I | -179.322 | 0 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Series A Preferred Stock | I | -312.000 | 0 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 15,0000 | 200.000 | 3.000 | 1.734.751 | ||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 1.043.429 | 1.534.751 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 179.322 | 491.322 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | HOFFMAN STEPHEN J | DRNA | Common Stock | I | 312.000 | 312.000 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | RA CAPITAL MANAGEMENT, LLC | DRNA | Series C Preferred Stock, par value $0.0001 | D | -1.428.571 | 0 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | DRNA | Common Stock, par value $0.0001 per share | I | 15,0000 | 1.000.000 | 15.000 | 2.428.571 | ||||
| 2014-02-05 | 2014-02-04 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | DRNA | Common Stock, par value $0.0001 per share | I | 1.428.571 | 1.428.571 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock Warrant (right to buy) | I | 7,00 | 21.697 | 21.697 | |||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series C Preferred Stock Warrants | I | 7,00 | -21.697 | 0 | |||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock Warrant | I | 250,00 | 755 | 755 | |||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series C Preferred Stock | I | -1.043.429 | 0 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series B Preferred Stock | I | -179.322 | 0 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Series A Preferred Stock | I | -312.000 | 0 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 15,0000 | 200.000 | 3.000 | 1.734.751 | ||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 1.043.429 | 1.534.751 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 179.322 | 491.322 | ||||||
| 2014-02-05 | 2014-02-04 | 4 | Skyline Venture Partners V LP | DRNA | Common Stock | I | 312.000 | 312.000 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | -156 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | -9.469 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | -3.535 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21.041 | 21.041 | |||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | -21.041 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | -1.276.243 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | -476.464 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13.004 | 13.004 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | BLAIR JAMES C By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1.752.707 | 1.752.707 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | -156 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | -9.469 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | -3.535 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21.041 | 21.041 | |||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | -21.041 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | -1.276.243 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | -476.464 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13.004 | 13.004 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DOVEY BRIAN H By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1.752.707 | 1.752.707 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | -156 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | -9.469 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | -3.535 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21.041 | 21.041 | |||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | -21.041 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | -1.276.243 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | -476.464 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13.004 | 13.004 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | TREU JESSE I By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1.752.707 | 1.752.707 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | -156 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | -9.469 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | -3.535 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21.041 | 21.041 | |||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | -21.041 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | -1.276.243 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | -476.464 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13.004 | 13.004 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | SCHOEMAKER KATHLEEN K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1.752.707 | 1.752.707 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | -156 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | -9.469 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | -3.535 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21.041 | 21.041 | |||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | -21.041 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | -1.276.243 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | -476.464 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13.004 | 13.004 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | VITULLO NICOLE By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1.752.707 | 1.752.707 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | 156 | 156 | |||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Warrant | I | 7,00 | -156 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | I | -9.469 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | I | -3.535 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | 21.041 | 21.041 | |||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Warrant | I | 7,00 | -21.041 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | I | -1.276.243 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | I | -476.464 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By DP VIII Associates, L.P. | DRNA | Common Stock | I | 13.004 | 13.004 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Halak Brian K By Domain Partners VIII, L.P. | DRNA | Common Stock | I | 1.752.707 | 1.752.707 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series C Preferred | I | -71.428 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series B Preferred | I | -8.586 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Series A Preferred | I | -10.000 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Common Stock | I | 90.014 | 90.194 | ||||||
| 2014-02-04 | 3 | Brookside Capital Trading Fund, L.P. | DRNA | Common Stock | I | 2.337.000 | ||||||||
| 2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Warrant | D | 7,00 | 156 | 156 | |||||
| 2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Warrant | D | 7,00 | -156 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Series C Preferred Stock | D | -9.469 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Series B Preferred Stock | D | -3.535 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | DP VIII Associates, L.P. | DRNA | Common Stock | D | 13.004 | 13.004 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Warrant | D | 7,00 | 21.041 | 21.041 | |||||
| 2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Warrant | D | 7,00 | -21.041 | 0 | |||||
| 2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Series C Preferred Stock | D | -1.276.243 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Series B Preferred Stock | D | -476.464 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Domain Partners VIII, L.P. | DRNA | Common Stock | D | 1.752.707 | 1.752.707 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Series C Preferred Stock | I | -572.142 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Series C Preferred Stock | I | -499.285 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Series C Preferred Stock | I | -161.071 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Series C Preferred Stock | I | -196.071 | 0 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 15,0000 | 400.500 | 6.008 | 972.642 | ||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 15,0000 | 349.500 | 5.242 | 848.785 | ||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 15,0000 | 112.000 | 1.680 | 273.071 | ||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 15,0000 | 138.000 | 2.070 | 334.071 | ||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design International II, L.P. | DRNA | Common Stock | I | 572.142 | 972.642 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Private Design Fund II, L.P. | DRNA | Common Stock | I | 499.285 | 848.785 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations International Master Fund, L.P. | DRNA | Common Stock | I | 161.071 | 273.071 | ||||||
| 2014-02-04 | 2014-02-04 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | DRNA | Common Stock | I | 196.071 | 334.071 | ||||||
| 2014-01-29 | 3 | FAMBROUGH DOUGLAS | DRNA | Common Stock | D | 12.300 | ||||||||
| 2014-01-29 | 3 | MADDEN DAVID | DRNA | Common Stock | D | 112.511 | ||||||||
| 2014-01-29 | 3 | LANGER DENNIS | DRNA | Common Stock | D | 8.873 | ||||||||
| 2014-01-29 | 3 | LANGER DENNIS Langer Family Holdings, LLP | DRNA | Common Stock | I | 180 | ||||||||
| 2014-01-29 | 3 | Miles Vincent J | DRNA | No securities are beneficially owned | D | 0 | ||||||||
| 2014-01-29 | 3 | Brown Bob D | DRNA | Common Stock | D | 19.339 | ||||||||
| 2014-01-29 | 3 | Weissman James B | DRNA | Common Stock | D | 12.116 |
